Please try another search
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
Name | Age | Since | Title |
---|---|---|---|
Sharvil Pankajbhai Patel | 45 | 1997 | MD & Executive Director |
Apurva Shishir Diwanji | 55 | 2016 | Independent Director |
Pankaj Ramanbhai Patel | 71 | 1995 | Non-Executive Chairman |
Mukeshbhai Mangalbhai Patel | 70 | 1997 | Non-Executive Non-Independent Director |
Ganesh Narayan Nayak | 69 | 2017 | COO & Executive Director |
Akhil A. Monappa | 46 | 2022 | Independent Director |
Bhadresh Kantilal Shah | 73 | 2018 | Independent Non-Executive Director |
Upasana Kamineni Konidela | 37 | 2022 | Independent Director |
Shelina P. Parikh | 56 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review